Cancer immunotherapy efficacy and machine learning

Expert Rev Anticancer Ther. 2024 Jan-Feb;24(1-2):21-28. doi: 10.1080/14737140.2024.2311684. Epub 2024 Feb 12.

Abstract

Introduction: Immunotherapy is one of the major breakthroughs in the treatment of cancer, and it has become a powerful clinical strategy, however, not all patients respond to immune checkpoint blockade and other immunotherapy strategies. Applying machine learning (ML) techniques to predict the efficacy of cancer immunotherapy is useful for clinical decision-making.

Areas covered: Applying ML including deep learning (DL) in radiomics, pathomics, tumor microenvironment (TME) and immune-related genes analysis to predict immunotherapy efficacy. The studies in this review were searched from PubMed and ClinicalTrials.gov (January 2023).

Expert opinion: An increasing number of studies indicate that ML has been applied to various aspects of oncology research, with the potential to provide more effective individualized immunotherapy strategies and enhance treatment decisions. With advances in ML technology, more efficient methods of predicting the efficacy of immunotherapy may become available in the future.

Keywords: Immunotherapy; cancer; deep learning; machine learning; omics.

Publication types

  • Review

MeSH terms

  • Clinical Decision-Making
  • Humans
  • Immunotherapy*
  • Machine Learning
  • Medical Oncology
  • Neoplasms* / therapy
  • Radiomics
  • Tumor Microenvironment